Nonhuman primates as models for the discovery and development of ebolavirus therapeutics

Bibliography

• Kuhn JH, Becker S, Ebihara H, Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol 2010;155:2083-103
   PubMed Web of Science ®Google Scholar
• Jahrling PB, Geisbert TW, Dalgard DW, Preliminary report: isolation of Ebola virus from monkeys imported to USA. Lancet 1990;335:502-5
   PubMed Web of Science ®Google Scholar
• Le Guenno B, Formenty P, Wyers M, Isolation and partial characterisation of a new strain of Ebola virus. Lancet 1995;345:1271-4
   PubMed Web of Science ®Google Scholar
• MacNeil A, Farnon E, Wamala J, Case fatality proportion of deaths for infection with Ebola Hemorrhagic Fever, Uganda. Emerg Infect Dis 2010;16:1969-72
   PubMed Web of Science ®Google Scholar
• Feldmann H, Jones SM, Schnittler HJ, Geisbert T. Therapy and prophylaxis of Ebola virus infections. Curr Opin Investig Drugs 2005;6:823-30
   PubMedGoogle Scholar
• Bausch DG, Towner JS, Dowell SF, Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007;196(Suppl 2):S142-7
   PubMedGoogle Scholar
• Bazhutin NB, Belanov EF, Spiridonov VA, The effect of the methods for producing an experimental Marburg virus infection on the characteristics of the course of the disease in green monkeys. Vopr Virusol 1992;37:153-6
   PubMedGoogle Scholar
• Leffel EK, Reed DS. Marburg and Ebola viruses as aerosol threats. Biosecur Bioterror 2004;2:186-91
   PubMed Web of Science ®Google Scholar
• Baskerville A, Bowen ET, Platt GS, The pathology of experimental Ebola virus infection in monkeys. J Pathol 1978;125:131-8
   PubMed Web of Science ®Google Scholar
• Bowen ET, Platt GS, Simpson DI, Ebola haemorrhagic fever: experimental infection of monkeys. Trans R Soc Trop Med Hyg 1978;72:188-91
   PubMed Web of Science ®Google Scholar
• Ellis DS, Bowen ET, Simpson DI, Stamford S. Ebola virus: a comparison, at ultrastructural level, of the behaviour of the Sudan and Zaire strains in monkeys. Br J Exp Pathol 1978;59:584-93
   PubMed Web of Science ®Google Scholar
• Fisher-Hoch SP, Platt GS, Lloyd G, Haematological and biochemical monitoring of Ebola infection in rhesus monkeys: implications for patient management. Lancet 1983;2:1055-8
   PubMed Web of Science ®Google Scholar
• Geisbert TW, Hensley LE, Larsen T, Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 2003;163:2347-70
   PubMed Web of Science ®Google Scholar
• Bray M, Davis K, Geisbert T, A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J Infect Dis 1999;179(Suppl 1):S248-58
   PubMedGoogle Scholar
• Connolly BM, Steele KE, Davis KJ, Pathogenesis of experimental Ebola virus infection in guinea pigs. J Infect Dis 1999;179(Suppl 1):S203-17
   PubMedGoogle Scholar
• Snoy PJ. Establishing efficacy of human products using animals: the US food and drug administration's “animal rule”. Vet Pathol 2010;47:774-8
   PubMed Web of Science ®Google Scholar
• Draft Guidance for Industry – essential elements for address efficacy under the animal rule. In: US Depart of Health and Human Services FaDA. Volume 74. Fed Regist; 2009. p. 3610-11
   Google Scholar
• Stroher U, Feldmann H. Progress towards the treatment of Ebola haemorrhagic fever. Expert Opin Investig Drugs 2006;15:1523-35
   PubMed Web of Science ®Google Scholar
• Carrion R. The common marmoset as a model for filovirus induced disease. XIVth International Conference on Negative Strand Viruses; Brugge, Belgium; 2010
   Google Scholar
• Bente D, Gren J, Strong JE, Feldmann H. Disease modeling for Ebola and Marburg viruses. Dis Model Mech 2009;2:12-17
   PubMed Web of Science ®Google Scholar
• Sanchez AJ, Geisbert TW, Feldmann H. In: Knipe D, Howley P, editors, Filoviridae: marburg and ebola viruses. Volume 2. Lippincott Williams & Wilkins, Philadelphia; 2007. p. 1409-48
   Google Scholar
• Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team. Bull World Health Organ 1978;56:247-70
   PubMed Web of Science ®Google Scholar
• Hutchinson KL, Rollin PE. Cytokine and chemokine expression in humans infected with Sudan Ebola virus. J Infect Dis 2007;196(Suppl 2):S357-63
   PubMedGoogle Scholar
• Leroy EM, Baize S, Volchkov VE, Human asymptomatic Ebola infection and strong inflammatory response. Lancet 2000;355:2210-15
   PubMed Web of Science ®Google Scholar
• Baize S, Leroy EM, Georges-Courbot MC, Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat Med 1999;5:423-6
   PubMed Web of Science ®Google Scholar
• Leroy EM, Baize S, Debre P, Early immune responses accompanying human asymptomatic Ebola infections. Clin Exp Immunol 2001;124:453-60
   PubMed Web of Science ®Google Scholar
• Leroy EM, Baize S, Mavoungou E, Apetrei C. Sequence analysis of the GP, NP, VP40 and VP24 genes of Ebola virus isolated from deceased, surviving and asymptomatically infected individuals during the 1996 outbreak in Gabon: comparative studies and phylogenetic characterization. J Gen Virol 2002;83:67-73
   PubMed Web of Science ®Google Scholar
• Sanchez A, Lukwiya M, Bausch D, Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol 2004;78:10370-7
   PubMed Web of Science ®Google Scholar
• Sanchez A, Wagoner KE, Rollin PE. Sequence-based human leukocyte antigen-B typing of patients infected with Ebola virus in Uganda in 2000: identification of alleles associated with fatal and nonfatal disease outcomes. J Infect Dis 2007;196(Suppl 2):S329-36
   PubMedGoogle Scholar
• Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 1978;56:271-93
   PubMed Web of Science ®Google Scholar
• Bwaka MA, Bonnet MJ, Calain P, Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis 1999;179(Suppl 1):S1-7
   PubMed Web of Science ®Google Scholar
• Bruce J, Brysiewicz P. Ebola fever: the African emergency. Int J Trauma Nurs 2002;8:36-41
   PubMedGoogle Scholar
• Formenty P, Hatz C, Le Guenno B, Human infection due to Ebola virus, subtype Cote d'Ivoire: clinical and biologic presentation. J Infect Dis 1999;179(Suppl 1):S48-53
   PubMedGoogle Scholar
• Outbreak of Ebola hemorrhagic fever Uganda, August 2000-January 2001. MMWR Morb Mortal Wkly Rep 2001;50:73-7
   PubMedGoogle Scholar
• Rowe AK, Bertolli J, Khan AS, Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 1999;179(Suppl 1):S28-35
   PubMed Web of Science ®Google Scholar
• Ryabchikova EI, Kolesnikova LV, Luchko SV. An analysis of features of pathogenesis in two animal models of Ebola virus infection. J Infect Dis 1999;179(Suppl 1):S199-202
   PubMedGoogle Scholar
• Reed DS, Hensley LE, Geisbert JB, Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques. Viral Immunol 2004;17:390-400
   PubMed Web of Science ®Google Scholar
• Johnson E, Jaax N, White J, Jahrling P. Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int J Exp Pathol 1995;76:227-36
   PubMed Web of Science ®Google Scholar
• Buchl SJ, Howard B. Hematologic and serum biochemical and electrolyte values in clinically normal domestically bred rhesus monkeys (Macaca mulatta) according to age, sex, and gravidity. Lab Anim Sci 1997;47:528-33
   PubMedGoogle Scholar
• Schuurman HJ, Smith HT. Reference values for clinical chemistry and clinical hematology parameters in cynomolgus monkeys. Xenotransplantation 2005;12:72-5
   PubMed Web of Science ®Google Scholar
• Zaki SR, Goldsmith CS. Pathologic features of filovirus infections in humans. Curr Top Microbiol Immunol 1999;235:97-116
   PubMed Web of Science ®Google Scholar
• Jaax NK, Davis KJ, Geisbert TJ, Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med 1996;120:140-55
   PubMed Web of Science ®Google Scholar
• Davis KJ, Anderson AO, Geisbert TW, Pathology of experimental Ebola virus infection in African green monkeys. Involvement of fibroblastic reticular cells. Arch Pathol Lab Med 1997;121:805-19
   PubMed Web of Science ®Google Scholar
• Geisbert TW, Young HA, Jahrling PB, Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am J Pathol 2003;163:2371-82
   PubMed Web of Science ®Google Scholar
• Gupta M, Mahanty S, Ahmed R, Rollin PE. Monocyte-derived human macrophages and peripheral blood mononuclear cells infected with ebola virus secrete MIP-1alpha and TNF-alpha and inhibit poly-IC-induced IFN-alpha in vitro. Virology 2001;284:20-5
   PubMed Web of Science ®Google Scholar
• Bray M, Geisbert TW. Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 2005;37:1560-6
   PubMed Web of Science ®Google Scholar
• Fuller CL, Ruthel G, Warfield KL, NKp30-dependent cytolysis of filovirus-infected human dendritic cells. Cell Microbiol 2007;9:962-76
   PubMed Web of Science ®Google Scholar
• Bosio CM, Aman MJ, Grogan C, Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. J Infect Dis 2003;188:1630-8
   PubMed Web of Science ®Google Scholar
• Gibb TR, Norwood DA Jr, Woollen N, Henchal EA. Viral replication and host gene expression in alveolar macrophages infected with Ebola virus (Zaire strain). Clin Diagn Lab Immunol 2002;9:19-27
   PubMedGoogle Scholar
• Zaki SR, Shieh WJ, Greer PW, A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 1999;179(Suppl 1):S36-47
   PubMedGoogle Scholar
• Baskerville A, Fisher-Hoch SP, Neild GH, Dowsett AB. Ultrastructural pathology of experimental Ebola haemorrhagic fever virus infection. J Pathol 1985;147:199-209
   PubMed Web of Science ®Google Scholar
• Rollin PE, Williams RJ, Bressler DS, Ebola (subtype Reston) virus among quarantined nonhuman primates recently imported from the Philippines to the United States. J Infect Dis 1999;179(Suppl 1):S108-14
   PubMedGoogle Scholar
• Geisbert TW, Hensley LE, Gibb TR, Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab Invest 2000;80:171-86
   PubMed Web of Science ®Google Scholar
• Fisher-Hoch SP, Platt GS, Neild GH, Pathophysiology of shock and hemorrhage in a fulminating viral infection (Ebola). J Infect Dis 1985;152:887-94
   PubMed Web of Science ®Google Scholar
• Rollin PE, Bausch DG, Sanchez A. Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J Infect Dis 2007;196(Suppl 2):S364-71
   PubMedGoogle Scholar
• Geisbert TW, Young HA, Jahrling PB, Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis 2003;188:1618-29
   PubMed Web of Science ®Google Scholar
• Villinger F, Rollin PE, Brar SS, Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis 1999;179(Suppl 1):S188-91
   PubMedGoogle Scholar
• Baize S, Leroy EM, Georges AJ, Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol 2002;128:163-8
   PubMed Web of Science ®Google Scholar
• Wauquier N, Becquart P, Padilla C, Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis 2010;4:e837
   PubMed Web of Science ®Google Scholar
• Bradfute SB, Warfield KL, Bavari S. Functional CD8+ T cell responses in lethal Ebola virus infection. J Immunol 2008;180:4058-66
   PubMed Web of Science ®Google Scholar
• Hensley LE, Young HA, Jahrling PB, Geisbert TW. Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol Lett 2002;80:169-79
   PubMed Web of Science ®Google Scholar
• Kroncke KD, Fehsel K, Suschek C, Kolb-Bachofen V. Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival. Int Immunopharmacol 2001;1:1407-20
   PubMed Web of Science ®Google Scholar
• Rubins KH, Hensley LE, Wahl-Jensen V, The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever. Genome Biol 2007;8:R174
   PubMed Web of Science ®Google Scholar
• Ksiazek TG, West CP, Rollin PE, ELISA for the detection of antibodies to Ebola viruses. J Infect Dis 1999;179(Suppl 1):S192-8
   PubMedGoogle Scholar
• Onyango CO, Opoka ML, Ksiazek TG, Laboratory diagnosis of Ebola hemorrhagic fever during an outbreak in Yambio, Sudan, 2004. J Infect Dis 2007;196(Suppl 2):S193-8
   PubMedGoogle Scholar
• Towner JS, Rollin PE, Bausch DG, Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004;78:4330-41
   PubMed Web of Science ®Google Scholar
• Feldmann H, Jones SM, Daddario-DiCaprio KM, Effective post-exposure treatment of Ebola infection. PLoS Pathog 2007;3:e2
   PubMed Web of Science ®Google Scholar
• Jahrling PB, Geisbert TW, Geisbert JB, Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. J Infect Dis 1999;179(Suppl 1):S224-34
   PubMedGoogle Scholar
• Bray M, Raymond JL, Geisbert T, Baker RO. 3-deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected mice. Antiviral Res 2002;55:151-9
   PubMed Web of Science ®Google Scholar
• Oswald WB, Geisbert TW, Davis KJ, Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys. PLoS Pathog 2007;3:e9
   PubMed Web of Science ®Google Scholar
• Spurgers KB, Sharkey CM, Warfield KL, Bavari S. Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viruses. Antiviral Res 2008;78:26-36
   PubMed Web of Science ®Google Scholar
• Stein DA. Inhibition of RNA virus infections with peptide-conjugated morpholino oligomers. Curr Pharm Des 2008;14:2619-34
   PubMed Web of Science ®Google Scholar
• Swenson DL, Warfield KL, Warren TK, Chemical modifications of antisense morpholino oligomers enhance their efficacy against ebolavirus infection. Antimicrob Agents Chemother 2009;53:2089-99
   PubMed Web of Science ®Google Scholar
• Warfield KL, Swenson DL, Olinger GG, Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers. PLoS Pathog 2006;2:5-13
   Web of Science ®Google Scholar
• Enterlein S, Warfield KL, Swenson DL, VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice. Antimicrob Agents Chemother 2006;50:984-93
   PubMed Web of Science ®Google Scholar
• Warren T, Warfield K, Wells J, Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nat Med 2010;16:991-4
   PubMed Web of Science ®Google Scholar
• Behlke MA. Progress towards in vivo use of siRNAs. Mol Ther 2006;13:644-70
   PubMed Web of Science ®Google Scholar
• de Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 2007;6:443-53
   PubMed Web of Science ®Google Scholar
• Vaishnaw AK, Gollob J, Gamba-Vitalo C, A status report on RNAi therapeutics. Silence 2010;1:1-14
   PubMedGoogle Scholar
• Geisbert TW, Lee AC, Robbins M, Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. Lancet 2010;375:1896-905
   PubMed Web of Science ®Google Scholar
• Robbins M, Judge A, Ambegia E, Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation. Hum Gene Ther 2008;19:991-9
   PubMed Web of Science ®Google Scholar
• Sullivan NJ, Geisbert TW, Geisbert JB, Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature 2003;424:681-4
   PubMed Web of Science ®Google Scholar
• Bukreyev A, Rollin PE, Tate MK, Successful topical respiratory tract immunization of primates against Ebola virus. J Virol 2007;81:6379-88
   PubMed Web of Science ®Google Scholar
• Warfield KL, Swenson DL, Olinger GG, Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge. J Infect Dis 2007;196(Suppl 2):S430-7
   PubMedGoogle Scholar
• Geisbert TW, Daddario-DiCaprio KM, Williams KJ, Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates. J Virol 2008;82:5664-8
   PubMed Web of Science ®Google Scholar
• Haller O, Kochs G, Weber F. Interferon, Mx, and viral countermeasures. Cytokine Growth Factor Rev 2007;18:425-33
   Google Scholar
• Bonjardim CA. Interferons (IFNs) are key cytokines in both innate and adaptive antiviral immune responses–and viruses counteract IFN action. Microbes Infect 2005;7:569-78
   PubMed Web of Science ®Google Scholar
• Feng Z, Cerveny M, Yan Z, He B. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR. J Virol 2007;81:182-92
   PubMed Web of Science ®Google Scholar
• Basler CF, Amarasinghe GK. Evasion of interferon responses by Ebola and Marburg viruses. J Interferon Cytokine Res 2009;29:511-20
   PubMed Web of Science ®Google Scholar
• Reid SP, Valmas C, Martinez O, Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1. J Virol 2007;81:13469-77
   PubMed Web of Science ®Google Scholar
• Mupapa K, Massamba M, Kibadi K, Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J Infect Dis 1999;179(Suppl 1):S18-23
   PubMedGoogle Scholar
• Jahrling PB, Geisbert JB, Swearengen JR, Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates. J Infect Dis 2007;196(Suppl 2):S400-3
   PubMedGoogle Scholar
• Jahrling PB, Geisbert J, Swearengen JR, Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch Virol Suppl 1996;11:135-40
   PubMedGoogle Scholar
• Dye J. Post-exposure transfer of immunoglobulin G from convalescent survivors protects rhesus macaques from marburg virus. In: Chemical and Biological Defense Science and Technology Conference; Orlando, Florida, USA; 2010
   Google Scholar
• Geisbert TW, Hensley LE, Jahrling PB, Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet 2003;362:1953-8
   PubMed Web of Science ®Google Scholar
• Hensley LE, Stevens EL, Yan SB, Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. J Infect Dis 2007;196(Suppl 2):S390-9
   PubMedGoogle Scholar
• Kortepeter MG, Martin JW, Rusnak JM, Managing potential laboratory exposure to ebola virus by using a patient biocontainment care unit. Emerg Infect Dis 2008;14:881-7
   PubMed Web of Science ®Google Scholar
• Bausch DG, Feldmann H, Geisbert TW, Outbreaks of filovirus hemorrhagic fever: time to refocus on the patient. J Infect Dis 2007;196(Suppl 2):S136-41
   PubMedGoogle Scholar
• Richards GA, Murphy S, Jobson R, Unexpected Ebola virus in a tertiary setting: clinical and epidemiologic aspects. Crit Care Med 2000;28:240-4
   PubMed Web of Science ®Google Scholar
• Ksiazek TG, Rollin PE, Williams AJ, Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999;179(Suppl 1):S177-87
   PubMedGoogle Scholar